New Key Statistics Module, Z-Score and F-Score
OTCPK:NVSEF Key Ratios
| Market Cap $ M | 193,463.01 |
| Enterprise Value $ M | 205,849.01 |
| P/E(ttm) | 13.78 |
| PE Ratio without NRI | 23.04 |
| Forward PE Ratio | 13.25 |
| Price/Book | 4.38 |
| Price/Sales | 3.95 |
| Price/Free Cash Flow | 17.42 |
| Price/Owner Earnings | 9.72 |
| Payout Ratio % | 0.84 |
| Revenue (TTM) $ M | 51,012.00 |
| EPS (TTM) $ | 7.10 |
| Beneish M-Score | -2.61 |
| 10-y EBITDA Growth Rate % | 3.20 |
| 5-y EBITDA Growth Rate % | -0.50 |
| y-y EBITDA Growth Rate % | 21.20 |
| EV-to-EBIT | 20.30 |
| EV-to-EBITDA | 11.11 |
| PEG | -- |
| Shares Outstanding M | 2,044.03 |
| Net Margin (%) | 28.64 |
| Operating Margin % | 19.83 |
| Pre-tax Margin (%) | 18.50 |
| Quick Ratio | 0.93 |
| Current Ratio | 1.16 |
| ROA % (ttm) | 13.10 |
| ROE % (ttm) | 29.19 |
| ROIC % (ttm) | 9.63 |
| Dividend Yield % | 4.02 |
| Altman Z-Score | 3.24 |
| Piotroski F-Score | 7.00 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA y-y | Y |
| Cash flow > Earnings | N |
| Lower Leverage y-y | Y |
| Higher Current Ratio y-y | N |
| Less Shares Outstanding y-y | Y |
| Gross Margin Increase y-y | Y |
| Higher Asset Turnover y-y | Y |
NVSEF Number of Guru Trades
NVSEF Volume of Guru Trades
Gurus Latest Trades with OTCPK:NVSEF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:NVSEF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Novartis AG Insider Transactions
No Available Data
News about OTCPK:NVSEF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers